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Abstract
Background: A number of prostaglandins (PGs) sensitize dorsal root ganglion (DRG) neurons and
contribute to inflammatory hyperalgesia by signaling through specific G protein-coupled receptors
(GPCRs). One mechanism whereby PGs sensitize these neurons is through modulation of
"thermoTRPs," a subset of ion channels activated by temperature belonging to the Transient
Receptor Potential ion channel superfamily. Acrid, electrophilic chemicals including
cinnamaldehyde (CA) and allyl isothiocyanate (AITC), derivatives of cinnamon and mustard oil
respectively, activate thermoTRP member TRPA1 via direct modification of channel cysteine
residues.
Results: Our search for endogenous chemical activators utilizing a bioactive lipid library screen
identified a cyclopentane PGD2 metabolite, 15-deoxy-Δ12,14-prostaglandin J2 (15d-PGJ2), as a TRPA1
agonist. Similar to CA and AITC, this electrophilic molecule is known to modify cysteines of cellular
target proteins. Electophysiological recordings verified that 15d-PGJ2 specifically activates TRPA1
and not TRPV1 or TRPM8 (thermoTRPs also enriched in DRG). Accordingly, we identified a
population of mouse DRG neurons responsive to 15d-PGJ2 and AITC that is absent in cultures
derived from TRPA1 knockout mice. The irritant molecules that activate TRPA1 evoke nociceptive
responses. However, 15d-PGJ2 has not been correlated with painful sensations; rather, it is
considered to mediate anti-inflammatory processes via binding to the nuclear peroxisome
proliferator-activated receptor gamma (PPARγ). Our in vivo studies revealed that 15d-PGJ2 induced
acute nociceptive responses when administered cutaneously. Moreover, mice deficient in the
TRPA1 channel failed to exhibit such behaviors.
Conclusion: In conclusion, we show that 15d-PGJ2 induces acute nociception when administered
cutaneously and does so via a TRPA1-specific mechanism.
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The prostaglandins (PGs) are a class of biomolecules
derived from arachidonic acid (AA) that are involved in a
variety of signaling processes including inflammation. For
example, PGE2 and PGI2 are produced during inflamma-
tion and contribute to the direct sensitization of nocicep-
tive neurons of the dorsal root ganglia (DRG).
Downstream of binding to its G protein-coupled receptor
(GPCR), PGE2 sensitizes nociceptive neurons to thermal
stimuli via PKA-dependent phosphorylation of the heat-
and capsaicin-gated Transient Receptor Potential (TRP)
ion channel TRPV1 [1]. TRPV1 is the founding mamma-
lian member of a subfamily of TRP channels gated by tem-
perature (dubbed thermoTRPs)[2].
TRPA1, first characterized as a thermoTRP channel gated
by noxious cold (although this finding is controversial)
[3] is activated by compounds that induce "burning" sen-
sations and therefore could be best classified as a "chem-
oTRP." Irritant chemicals ligands of TRPA1 include allyl
isothiocyanate (AITC), cinnamaldehyde (CA), allicin,
acrolein and formalin[4-8]. TRPA1 is also tightly coupled
to bradykinin signaling and is activated by agents gener-
ated by oxidative stress[4,7,8]. Two groups have recently
shown that covalent modification of cytoplasmic N-ter-
minal cysteine residues via the Michael addition reaction
is a common mode of action of several TRPA1 ago-
nists[9,10].
In order to identify novel and endogenous TRPA1 activa-
tors, we performed a bioactive lipid library screen and
describe here our findings that 15-deoxy-Δ12,14-prostag-
landin J2 (15d-PGJ2) a cyclopentane prostaglandin metab-
olite of PGD2[11], specifically activates this channel and
not other thermoTRPs enriched in DRG. Similar to AITC
and CA, 15d-PGJ2 is characterized by an electrophilic α,β-
unsaturated carbonyl group capable of undergoing a
Michael addition with nucleophilic groups on cysteine
residues. A role of 15d-PGJ2 in peripheral nociception has
not been described previously; rather this molecule is best
characterized as an anti-inflammatory agent[12]. How-
ever, we have identified a population of DRG nociceptive
neurons that respond to 15d-PGJ2 and the TRPA1-specific
agonist AITC. We therefore further hypothesized that 15d-
PGJ2 plays an in vivo role in acute peripheral nociceptive
signaling via TRPA1 activation. Accordingly, we found
that 15d-PGJ2 induced acute nociceptive responses when
administered cutaneously in mice. This effect is specific to
TRPA1 as these nociceptive behaviors are significantly
attenuated in TRPA1 knockout mice. Taken together our
results demonstrate a novel TRPA1-dependent role of
15d-PGJ2 in acute pro-nociception.
Materials and methods
Bioactive Lipid Library Screen
Intracellular calcium measurements were performed
using a Fluorometric Imaging Plate Reader (FLIPR). Mus
musculus TRPA1 (mTRPA1)-CHO cells were seeded at
6000 cells/well into black-walled base 384-well plates and
were grown for 2 days. Cells were induced for mTRPA1
expression as described and loaded with Fluo-3 according
to protocol (Molecular Probes). The plates were placed
into a FLIPR (Molecular Devices, UK) to monitor cell flu-
orescence (EX _ 488 nM; EM _ 540 nM) before and after
the 201 lipids contained in the Biomol Bioactive Lipid
Library were added[4].
Electrophysiology
HeLa cells were seeded at a density of 2 × 105 cells per 35
mm dish 24 hr prior to transfection in Dulbecco's modi-
fied Eagle's medium (DMEM) containing 10% fetal
bovine serum. Cells were co-transfected with plasmids
containing mTRPA1, mTRPV1 or mTRPM8 and GFP
(green fluorescent protein) in pcDNA3.1 using Lipo-
fectAMINE and OPTI-MEM I Reduced Serum Medium
(Life Technologies). Green fluorescence from cells
expressing GFP was detected with the aid of a Nikon
microscope equipped with a mercury lamp light source
and a GFP filter (emission wavelength, 510 nm). Cells
were used 1–2 days after transfection. Only cells showing
normal ellipsoidal shape were used.
Gigaseal was formed with pipettes with desired resistance
(2–5 Mohms). Current was recorded with an Axopatch
200 patch-clamp amplifier, low-pass filtered at 3 KHz
using an 8-pole Bessel filter (902-LPF), digitized using
Digidata1322A, and stored on computer disk. Digitized
data were analyzed (pClamp 9.0) to obtain channel activ-
ity (NPo; where N is the number of channels in the patch
and Po is the open probability), and amplitude histograms
to obtain single channel conductance. Current tracings
shown in figures have been filtered at 1 KHz. For whole-
cell recordings, bath solution contained 126 mM NaCl, 4
mM KCl, 2 mM EGTA, 1 mM MgCl2, 10 mM HEPES, 5
mM glucose, and pipette solution contained 130 mM
CsCl, 2 mM EGTA, 1 mM MgCl2, 2 mM ATP and 100 mM
GTP and 10 mM HEPES (pH 7.3). For cell-attached
patches, pipette and bath solutions contained (in mM):
126 mM NaCl, 4 mM KCl, 2 mM EGTA, 1 mM MgCl2, 10
mM HEPES, and 5 mM glucose (pH 7.3). Student's t test
was used to test for significance (p < 0.05). All experi-
ments were done at room and bath temperatures of 23 ±
1°C.
DRG culture and intracellular calcium imaging
Calcium imaging experiments of DRG neurons were per-
formed as described[4]. Briefly, DRG neurons from all spi-
nal levels were rapidly dissected from adult mice andPage 2 of 9
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were performed in quadruplicate. For DRGs, 100 μM15d-
PGJ2 (3 min pulse), 100 μM AITC (2 min pulse) and 1 μM
capsaicin (2 min) were applied with a 4-min washout in
between each stimulus.
Behavioral Assays
Male C57BL6/J and TRPA1 mutant strain mice (obtained
from David P. Corey and backcrossed to C57BL6/J for 5
generations) of 10–12 weeks age were used. Experiment-
ers were blind with respect to genotype. Responses were
averaged and analyzed using Student's t-test.
Animals were placed in individual Plexiglas boxes on a
grid platform and habituated to the testing environment
for one hour. After the habituation period, each mouse
was injected on the plantar surface of the right hindpaw
with 10 μl of 15 nmol 15d-PGJ2 diluted in 10% DMSO/
normal saline (vehicle). This concentration was based on
dose-response behaviors with injections ranging from
2.5–25 nmol concentrations of 15d-PGJ2 compared to
vehicle. Behavior was recorded for 10 min after intra-
plantar injection. Observed variables were latency of
response to licking and lifting of the paw as well as time
spent licking/lifting of the paw.
Compounds
AITC, menthol and capsaicin were purchased from Sigma
Chemical Co. PGD2, PGJ2, delta12-PGJ2 and15d-PGJ2
were purchased from Biomol. For calcium imaging and
electrophysiology experiments, PGs were dissolved in
DMSO at a stock concentration of 20 mM and used at the
final DMSO concentration of 0.1% or less.
Results
TRPA1 is specifically activated by 15d-PGJ2
In order to identify novel TRPA1 agonists, we employed a
Fluo-3 FLIPR-based screen of >200 bioactive lipids. This
search identified that 15d-PGJ2 activated mTRPA1 in a
dose dependent manner (Figure 1A–B). In these prelimi-
nary screen experiments, ATP was used as a control for cell
viability as CHO cells show endogenous and robust
responses to this compound. To determine whether 15d-
PGJ2 directly activates TRPA1, whole-cell current was
recorded from HeLa cells expressing mTRPA1 at a holding
membrane potential of -40 mV. Application of 15d-PGJ2
to the bath solution rapidly increased the inward current
that slowly decreased with time (Figure 2A). In the cell-
attached patches used in this study, the number of TRPA1
channels expressed ranged from 3 to 14. In cell-attached
patches with pipette potential held at -60 mV to record
outward current, application of 15d-PGJ2 to the external
solution also activated single channel currents in all
patches tested (Figure 2B). Control solution containing
0.1% DMSO did not activate any channels (n = 8). Single
channels activated by 15d-PGJ2 are shown at expanded
time scale in the inset of Figure 2B. The single channel
conductance of the inward current (+40 mV pipette
potential) was 87 ± 3 pS (n = 3), based on measurements
at two membrane potentials 0 and +40 mV. This is similar
to the single channel conductance values reported earlier
[13,14]. The single channel properties of TRPA1 expressed
in HeLa cells have recently been characterized in detail
[14] and therefore not described here. Because TRPA1
switches to a conformation that is insensitive to thiol-
reactive compounds when inside-out patch is formed, all
experiments were done using cell-attached patches. In
cell-attached patches with pipette potential at +40 mV to
record inward current, 15d-PGJ2 also activated TRPA1.
Further addition of 50 μM AITC produced a much greater
activation of TRPA1 (Figure 2C). In HeLa cells transfected
with plasmid containing only GFP DNA, 15d-PGJ2 did
not activate any channels (n = 5). As 50 μM AITC maxi-
mally activates TRPA1, these results show that the current
activated by 20 μM 15d-PGJ2 is ~26% of the peak current
(Figure 2C, inset) under these experimental conditions. As
15d-PGJ2 and AITC were added to the bath solution out-
side of the pipette, the result also shows that the com-
pounds must cross the membrane and activate TRPA1
from the intracellular side of the membrane. The true con-
centration of PGJ2 in the cell that interacts with TRPA1 is
difficult to know. Because the activation of TRPA1 by
AITC was not easily reversible even after several minutes
of washout, whether PGJ2 sensitized the action of AITC
could not be determined in the same cell. In three cell-
attached patches with 10 μM ruthenium red in the pipette,
addition of 15d-PGJ2 failed to activate TRPA1 (data not
shown), further showing that TRPA1 is the target of this
prostaglandin. In cells expressing TRPV1, application of
15d-PGJ2 failed to activate TRPV1, but subsequent addi-
tion of capsaicin strongly activated the channels, as pre-
dicted (Figure 2D). Similarly, in cells expressing TRPM8,
application of 15d-PGJ2 failed to activate any channels,
but subsequent addition of menthol elicited strong activa-
tion (Figure 2E). Although other TRP ion channels were
not tested, these results suggest that 15d-PGJ2 is specific
for TRPA1 among three TRP channels tested.
To test whether PGD2 itself or related PGD2 derivatives
also activate TRPA1, we tested 12d-PGJ2, PGJ2 and PGD2.
Similar to results obtained in our FLIPR-based library
screen, none of these compounds were able to activate
TRPA1 at similar concentrations, although AITC showed
clear activation of TRPA1 in the same patches (Figure 3A–
C). Under our experimental condition, it takes many min-
utes (~10 min) to washout the effect of AITC on TRPA1
and the recovery phase is not shown. Taken together,
these data demonstrate that 15d-PGJ2 is a specific activa-
tor of TRPA1.Page 3 of 9
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neurons
To discover if 15d-PGJ2 activates TRPA1-expressing sen-
sory neurons, we performed calcium imaging of cultured
adult TRPA1 knockout and wildtype littermate DRG neu-
rons in response to 15d-PGJ2, AITC and capsaicin. In sup-
port of specific activation of TRPA1, 100 μM 15d-PGJ2
induced increased fluorescence ratios (scored as 50%
FLIPR-based library screen of 15d-PGJ2 activation of TRPA1igure 1
FLIPR-based library screen of 15d-PGJ2 activation of TRPA1. A. Fluorescence increases of TRPA1-expressing or 
mock transfected controls in response to a 50 μM 15d-PGJ2 stimulus. Traces represent average increases of cells from a 96-
well plate. B. Fluorescence increases shown as minigraphs within 48 wells of TRPA1-expressing cells in response to increasing 
concentrations of 15d-PGJ2. All concentrations are in μM. 100 μM ATP and buffer were delivered as controls (the strain of 
CHO cell used exhibits endogenous ATP response and was used to ensure cell viability after compound addition).Page 4 of 9
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15d-PGJ2 activates TRPA1, but not TRPV1 or TRPM8, expressed in HeLa cellsFigure 2
15d-PGJ2 activates TRPA1, but not TRPV1 or TRPM8, expressed in HeLa cells. A. Whole-cell current was recorded 
at a membrane potential of -40 mV (n = 3). B. A cell-attached patch shows activation of TRPA1 by 15d-PGJ2. Pipette potential 
was held at -60 mV to record outward current (n = 4). 15d-PGJ2 increased the channel activity (NPo) from a basal level of 0.03 
± 0.01 to 2.10 ± 0.30. C. A cell-attached patch shows activation of TRPA1 by 15d-PGJ2 and AITC. Pipette potential was held at 
+40 mV to record inward current. The bars in the graph represent the mean ± SD of 4 determinations, and are significantly dif-
ferent from each other. The channel activity (NPo) elicited by AITC was 6.6 ± 1.4. D-E. In HeLa cells expressing TRPV1 or 
TRPM8, 15d-PGJ2 had no effect, whereas capsaicin or menthol respectively, activated TRPV1 or TRPM8 (n = 4). Pipette poten-
tial was held at -40 mV. The large activation for TRPV1 by capsaicin could not be recorded at the amplifier gain setting used to 
show the lack of effect of 15d-PGJ2, but full washout was always observed following removal of capsaicin.
Molecular Pain 2008, 4:30 http://www.molecularpain.com/content/4/1/30above baseline fluorescence) in 27% of cultured DRG
neurons derived from wildtype mice (387 total neurons).
Of these, 90% and 83% were AITC- and capsaicin-respon-
sive respectively (Figure 4A). In DRG cultures (360 total
neurons) derived from TRPA1 knockout mice, 100 μM
15d-PGJ2 and 100 μM AITC overall failed (2.3% and 0.5%
of total, respectively) to elicit significant fluorescence
increases, while capsaicin responses were intact (Figure
4B). These data show that 15d-PGJ2 specifically activates a
subset of predicted TRPA1-expressing DRG neurons.
15d-PGJ2 elicits acute nociceptive behavior via a TRPA1-
dependent mechanism
The TRPA1 agonists including AITC, cinnamaldehyde and
formaldehyde induce acute nociceptive behaviors includ-
ing licking and flicking when injected in the hindpaw[4-
6,15,16]. Peripheral nociceptive behaviors have not been
reported in response to 15d-PGJ2. Therefore, we per-
formed a dose-response study using 2.5–25 nmol 15d-
PGJ2 hindpaw injection. A dose of 15 nmol was required
in 10–12 week-old mice to elicit significant lifting and
licking of the hindpaw compared to vehicle (Figure 5A).
Therefore, all future studies utilizing wildtype and age-
matched 10–12 week-old TRPA1 knockout littermates
were performed using 15 nmol 15d-PGJ2. As shown in
Figure 5, 15 nmol 15d-PGJ2 induced significant nocicep-
tive behaviors including licking and lifting of the hindpaw
compared to vehicle injection in C57BL/6J mice. The
latency to the first response was scored as initial licking of
the paw. Then the mice behaved by spending a significant
amount of time both licking the injected paw and keeping
it off the surface of the testing apparatus by lifting. To
determine whether nociceptive behaviors were specific to
TRPA1 activation, we performed similar experiments
using wildtype and TRPA1 knockout littermates. As
shown in Figure 5B, these behaviors were essentially
absent in TRPA1-deficient mice, suggesting that acute
peripheral nociception induced by 15d-PGJ2 occurs via
specific activation of this channel.
Discussion
Results of the present study reveal a previously uncharac-
terized role of 15d-PGJ2 in peripheral nociception. We
show that 15d-PGJ2, similar to all known TRPA1 ligands,
PGD2 and its metabolites do not activate TRPA1Figure 3
PGD2 and its metabolites do not activate TRPA1. A-
C. Cell-attached patches show lack of activation of TRPA1 by 
12d-PGJ2, PGJ2 and PGD2. In the same cells, AITC caused 
strong activation (n = 5 each). Pipette potential was held at 
+40 mV.
15d-PGJ2 specifically activates TRPA1-expressing DRG neu-ronsFigure 4
15d-PGJ2 specifically activates TRPA1-expressing 
DRG neurons. Traces represent increased fluorescence 
ratios of DRG neurons cultured from TRPA1 WT (A) or 
knockout (B) mice in response to 15d-PGJ2, AITC and capsa-
icin. Panels A and B illustrate responses of neurons from sep-
arate calcium experiments (~100 neurons per experiment 
are illustrated). All experiments were performed in quadru-
plicate from cultures derived from 10 animals per genotype. 
Compound application is indicated by black bars (Caps, Cap-
saicin).Page 6 of 9
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Intraplantar injection of 15d-PGJ2 causes acute nociceptive responses via TRPA1Figure 5
Intraplantar injection of 15d-PGJ2 causes acute nociceptive responses via TRPA1. (A) 10 μL of vehicle (10% DMSO 
in saline) or 15 nmol 15d-PGJ2 was injected into the hindpaw of C57BL/6J mice (n = 5 per group) and nociceptive behaviors 
(licking and lifting of the paw) for 10 minutes. 15d-PGJ2 caused significant nociceptive responses compared to vehicle. (B) 15d-
PGJ2-induced nociceptive behaviors are absent in TRPA1 knockout mice (n = 5 per group). ***p < 0.001
Molecular Pain 2008, 4:30 http://www.molecularpain.com/content/4/1/30induces pain. We further demonstrate a causal link
between 15d-PGJ2-induced nociception and TRPA1 acti-
vation at the cellular and behavioral levels.
Intriguingly, 15d-PGJ2 is best characterized as a potent
anti-inflammatory agent and not as a molecule that
induces acute or long-term inflammatory pain. Instead,
the resolution of the inflammatory state appears to corre-
late with increasing levels of 15d-PGJ2 within tissue flu-
ids[17]. Like other cyclopentane prostaglandins, 15d-
PGJ2 does not function via a specific GPCR. Rather, the
anti-inflammatory effects of 15d-PGJ2 are mediated by
activation of the transcription factor peroxisome prolifer-
ator-activated receptor gamma (PPARγ) [18-20]. For
example, 15d-PGJ2 represses the transcription of a
number of pro-inflammatory factors including inducible
nitric oxide synthase, cyclooxygenase-2 and tumor necro-
sis factor-α[21,22]. 15d-PGJ2 also acts independent of
PPARγ to alter the activity of inflammatory molecules. It is
thought to directly alkylate nucleophilic cysteine residues
of NF-κB, thereby inhibiting DNA binding by NF-κB [23].
Similarly, TRPA1 is activated by the covalent binding of
electrophiles to cysteines, providing a likely mechanism
whereby 15d-PGJ2 activates this channel[9,10].
The results of our initial compound library screen were
borne out by follow-up electrophysiological recordings
showing that 15d-PGJ2directly activates TRPA1. In con-
trast to 15d-PGJ2, the J series PGD2 metabolites PGJ2 and
12d-PGJ2, which also contain reactive electrophilic car-
bons, failed to activate TRPA1 in our studies. A recent
study by Taylor-Clark et al., which examined the activa-
tion of human TRPA1 using heterologous expression in
HEK cells, found that 12d-PGJ2 was able to activate this
channel[24]. Discrepancies between this study and our
study could be due to concentrations tested (5 times
greater concentrations were utilized by Taylor-Clark et
al.), expression systems used or to subtle species differ-
ences in channel structure. The in vivo behavioral studies
described here extend those of Taylor-Clark et al. by dem-
onstrating that 15d-PGJ2 activation of TRPA1 is physio-
logically relevant. Lastly, during the preparation of this
manuscript Andersson et al. published an article on the
activation of TRPA1 by mediators of oxidative stress
(including 15d-PGJ2) which confirm our findings pre-
sented here [26].
Consistent with a physiological role of 15d-PGJ2 in the
activation of TRPA1, we identified a population of DRG
neurons sensitive to 15d-PGJ2, AITC and capsaicin.
TRPA1-expressing neurons occur as a subset of TRPV1-
expressing neurons in the DRG; whereas TRPM8 is
expressed in a separate population. These results support
our electrophysiological studies showing that 15d-PGJ2
does not activate TRPV1 or TRPM8. In further support of
specific activation of TRPA1, a negligible number of 15d-
PGJ2/AITC responsive neurons were detected in cultures
derived from TRPA1 knockout mice compared to wildtype
(~2% vs. 90% respectively).
Specific agonists of TRPA1 cause acute nociceptive behav-
iors in vivo when administered cutaneously. Therefore, we
investigated responses to intraplantar injection of 15d-
PGJ2. Both C57BL/6J and TRPA1 wildtype mice
responded robustly by licking of the injected paw as well
as lifting of the paw from the surface of the testing appa-
ratus. These behaviors were dramatically abolished in
TRPA1 knockout mice, suggesting that 15d-PGJ2-induced
acute peripheral nociception is mediated by TRPA1.
Previous studies have demonstrated a definitive role of
TRPA1 in transmitting acute and inflammatory pain[4-
8,15,16,25]. Here we show that 15d-PGJ2, a molecule
with no known membrane receptor that is implicated in
anti-inflammatory pathways, specifically activates TRPA1,
an ion channel expressed in the cell membrane of nocice-
ptive neurons. We also show that similar to other TRPA1
agonists, 15d-PGJ2 induces robust, acute nociceptive
behaviors in vivo. Our data also support that 15d-PGJ2-
induced peripheral nociception in vivo occurs through
TRPA1 signaling. Collectively, our findings elaborate on a
novel function of 15d-PGJ2 in peripheral nociception and
identify TRPA1 as its principal receptor in pain-sensing
DRG neurons.
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